American Renal Associates Holdings, Inc
ARA
ARA was delisted on the 25th of January, 2021.
56 hedge funds and large institutions have $187M invested in American Renal Associates Holdings, Inc in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 5 closing their positions.
5% more capital invested
Capital invested by funds: $178M → $187M (+$9.14M)
0% more funds holding
Funds holding: 56 → 56 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
2.53% less ownership
Funds ownership: 80.94% → 78.41% (-2.5%)
33% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Los Angeles Capital Management
Los Angeles,
California
|
+$315K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$251K |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$206K |
| 4 |
Renaissance Technologies
New York
|
+$183K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$91.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$805K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$262K |
| 3 |
State Street
Boston,
Massachusetts
|
-$229K |
| 4 |
D.E. Shaw & Co
New York
|
-$192K |
| 5 |
Jane Street
New York
|
-$174K |
ARA Hedge Fund Activity: Q3 2020 in Review
56 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q3 2020, worth a combined $187M — up 5.1% from $178M a quarter earlier.
Fund positioning in ARA was balanced in Q3 2020: 5 funds opened new positions, 5 closed out, 14 added to existing stakes and 21 trimmed.
The largest buyer was Los Angeles Capital Management, opening a new position worth an estimated $315K. The largest seller was Morgan Stanley, cutting an estimated $805K.
- 56 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $187M of American Renal Associates Holdings, Inc stock for Q3 2020, up 5.1% quarter-over-quarter.
- 5 funds opened new American Renal Associates Holdings, Inc positions in Q3 2020 and 5 closed out, a net change of 0 holders.
- The largest American Renal Associates Holdings, Inc buyer in Q3 2020 was Los Angeles Capital Management, an estimated $315K added.
- The largest American Renal Associates Holdings, Inc seller in Q3 2020 was Morgan Stanley, an estimated $805K sold.
Based on aggregated 13F filings for Q3 2020.